408 related articles for article (PubMed ID: 20001347)
1. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey.
Favaloro EJ; Wong RC
Pathology; 2009; 41(7):666-75. PubMed ID: 20001347
[TBL] [Abstract][Full Text] [Related]
2. Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: a potpourri of problems, a compilation of possible solutions.
Favaloro EJ; Wong RC
Semin Thromb Hemost; 2008 Jun; 34(4):389-410. PubMed ID: 18814073
[TBL] [Abstract][Full Text] [Related]
3. Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulants.
Favaloro EJ
Int J Lab Hematol; 2013 Jun; 35(3):269-74. PubMed ID: 23590654
[TBL] [Abstract][Full Text] [Related]
4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
Galli M
Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
[TBL] [Abstract][Full Text] [Related]
6. Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays.
Favaloro EJ; Wong RC
Clin Chem Lab Med; 2011 Mar; 49(3):447-61. PubMed ID: 21275808
[TBL] [Abstract][Full Text] [Related]
7. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
Suh-Lailam BB; Cromar A; Davis KW; Tebo AE
Int J Clin Exp Pathol; 2012; 5(3):210-5. PubMed ID: 22558475
[TBL] [Abstract][Full Text] [Related]
8. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
Galli M; Finazzi G; Bevers EM; Barbui T
Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
[TBL] [Abstract][Full Text] [Related]
9. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
[TBL] [Abstract][Full Text] [Related]
10. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
[TBL] [Abstract][Full Text] [Related]
11. Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity.
Simmons DP; Herskovits AZ; Battinelli EM; Schur PH; Lemire SJ; Dorfman DM
Clin Chem Lab Med; 2018 Jul; 56(8):1289-1296. PubMed ID: 27305702
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid Antibody Testing for Anti-cardiolipin and Anti-β2 Glycoprotein I Antibodies Using Chemiluminescence-Based Panels.
Favaloro EJ; Mohammed S; Vong R; Pasalic L
Methods Mol Biol; 2023; 2663():297-314. PubMed ID: 37204719
[TBL] [Abstract][Full Text] [Related]
13. A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays.
Wong RC; Favaloro EJ
Semin Thromb Hemost; 2008 Jun; 34(4):361-72. PubMed ID: 18814070
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
15. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
16. Clinical audit of antiphospholipid antibody testing in tertiary practice: towards improved relevance in thrombophilia investigations.
Favaloro EJ; Reben R; Mohammed S; Koutts J
Intern Med J; 2012 Apr; 42(4):427-34. PubMed ID: 20681961
[TBL] [Abstract][Full Text] [Related]
17. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
[TBL] [Abstract][Full Text] [Related]
18. Laboratory tests for the antiphospholipid syndrome.
Pericleous C; Ripoll VM; Giles I; Ioannou Y
Methods Mol Biol; 2014; 1134():221-35. PubMed ID: 24497366
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies: evaluation of the thrombotic risk.
Devreese KM
Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
[TBL] [Abstract][Full Text] [Related]
20. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
Front Immunol; 2021; 12():754469. PubMed ID: 34790198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
